Antigen Rapid Tests for COVID-19 1. mLab mscreen Corona Antigen Test - Simple nasal swap or nasopharyngeal swab / 2. Laihe Novel - Nasopharyngeal swab / 3. Nal von minden dedico plus - Simple nasal swap or nasopharyngeal swab / 4. Joysbio Saliva Rapid Test Kit - Saliva Test Kit CE IVD certified, in stock in Germany, min. 10000 pcs, from EUR 4.99, free delivery within Germany
Laihe / Novel Corona Antigen Test Nasopharyngeal swab / under 30 minutes / Sensitivity 95.07% / CE marked for diagnostic use in EU and associated countries / Paul Ehrlich Institute and IVD / box of 100 / Min order 10000 pcs / Free delivery within Germany / In stock in Germany
Nal von minden / dedico plus Simple nasal swap or nasopharyngeal swab / under 30 minutes / Sensitivity 97.10% / TCID50 75.5 / CE IVD marked for diagnostic use in EU and associated countries / Paul Ehrlich Institute / box of 100 / Min order 10000 pcs / Free delivery within Germany / In stock in Germany
Joysbio Saliva Rapid Test Kit - Saliva Test Kit for public use / under 30 minutes / Sensitivity 95.10% / TCID50 320 / CE IVD marked for public use / In stock in Germany
mLab / m-screen Corona Antigen Test Simple nasal swap* or nasopharyngeal swab** / Under 30 minutes / Sensitivity 98.32%** and 97.25%* / TCID50 115 / In stock in Germany / CE IVD marked for diagnostic use in EU and associated countries / Paul Ehrlich Institute / German Manufacturer / Min order 10000 pcs / Free delivery within Germany / In stock in Germany
COVID-19 (2019-nCoV) Coronavirus IgG/IgM Rapid Test Kit Principle: based on Colloidal Gold Method, to detect COVID-19 IgG/IgM Antibody in serum, plasma, whole blood qualitatively. Easy to operate, results can be obtained in 15 minutes. Component: 25 tests cassttes/ 25 dropper/ 25 tubes of dilution buffer/25 Alcohol pad/ 25 Lancet/ 1 manual Certificate: CE, ISO13485, ISO9001
1. Nasopharynx swab specimen, non-invasive 2. Very simple to use 3. Convenient, no devices required 4. Rapid, results within 20 minutes 5. Cost-efficient 6:Listed on German BfArm ,got approval by PEI Clinical report from local CDC Sensitivity is 97.14%, Specificity is 100%, total accuracy rate is 99.68%.
A rapid test for the qualitative detection of novel coronavirus antigens in nasal, Nasopharyngeal (NP) swab & Oropharyngeal (OP) swab. The S2 Covid-19 Rapid Antigen Test Kit (swab) is an in vitro diagnostic test for the qualitative detection of novel coronavirus antigens in Nasal swab, Nasopharyngeal swab (NP) and Oropharyngeal swab (OP), using the rapid immunochromatographic method. The identification is based on the monoclonal antibodies specific for the novel coronavirus antigen.
RAPIGEN South Korea-based RapiGEN is a leading manufacturer of in vitro diagnostic industry. The company has developed and manufactured rapid diagnostic test devices for over 15 years. RapiGEN's core raw material, black gold particle, has brought innovation to the in vitro rapid test field with their high specificity, sensitivity, and reproducibility.
Ionebio Ionebio produces the iLAMP Novel-CoV19 Detection Kit, a real-time Reverse Transcription LAMP-PCR assay system. The test kits are widely used in South Korea, including at ports of entry into the country. Ionebio has secured a facility in the United States which can produce 1 million test per day. This PCR has a 20 minute test time.
This antigen test is suitable for the qualitative detection of novel coronavirus in Saliva/Sputum/Stool/NP Swab/OP Swab samples (all methods in single test). Result in 15mins
The product is based on the principle of antigen-antibody reaction and immunoassay technique. The test device contains colloidal gold labeled SARS-CoV-2 recombinant protein, mouse-anti human IgG antibody immobilized in G test area, mouse-anti human IgM antibody immobilized in M test area and the corresponding antibody in quality control area (C). During the test, when the SARS-CoV-2 IgM antibody level in the sample is at or above the limit of detection of the test, the SARS-CoV-2 IgM antibody in the sample binds to the colloidal gold labeled SARS-CoV-2 recombinant protein which is pre-coated on a gold label pad. The conjugates migrate upward through capillary effect and would be captured by mouse-anti human IgM antibody immobilized in M test area subsequently and this produces a purple-red band appears in the M test area. When the SARS-CoV-2 IgG antibody level in the sample is at or above the limit of detection of the test, the SARS-CoV-2 IgG antibody in the sample binds to the colloidal gold labeled SARS-CoV-2 recombinant protein which is pre-coated on a gold label pad. Theconjugates migrate upward through capillary effect and would be captured by mouse-anti human IgG antibody immobilized in G test area subsequently and this produces a purple-red band appears in the G test area. If it is a negative sample, there is not a purple-red band appeared in the M and G test area. Regardless of the presence or absence of the SARS-CoV-2 antibody in the sample, a purple-red band will appear in the quality control area (C). The purple-red band in the quality control area (C) is a criterion for judging whether there is enough sample and whether the chromatography process is normal. It also serves as the internal control standard for reagents.
Covid Ab IgG/IgM Ab Whole blood test device Sensitivity: 86.94% Specificity: 99.31% Accuracy: 93.36%
Co-virion Rapid Antigen Test is an immunochromatographic test designed to qualitatively detect SARS-CoV- 2 antigen in nasopharyngeal geal swab specimens. It is intended to aid in the rapid diagnosis of SARS-CoV-2 infections. Co-virion Rapid Antigen Test is an immunochromatographic test designed to detect the nucleocapsid protein of SARS-CoV-2 in nasopharyngeal swabs (NP). The test strip contains colloidal-gold conjugated particles with monoclonal antibodies against the nu- cleo- capsid protein of SARS-CoV-2. The capture antibodies for nucleocapsid protein of SARS-CoV-2 are coated on the nitrocellulose membrane. When the sample is applied to the sample window (S well), the conjugates dried in the reagent pad are dissolved and migrate along with the sample. If SARS-CoV-2 is present in the sample, a complex formed between the anti-SARS-CoV-2 conjugate and the virus will be captured by the specific an- ti-SARS-CoV-2 monoclonal antibodies coated on the test line region (T), which develops a red line in T region. Presence of T line indicates a positive result. There is also an internal control line to check the accuracy of the test performance. The control line is coated with goat anti-Rabbit IgG antibody which binds to the gold labeled antibody. Failure to form C line confirms the incorrect procedural technique.
Kit Rapid Test, Hotgen, Clungene, Hightop, Newgene
Flowflex antigen kits
Bacterial Vaginosis Rapid Test Kit core Chromogenic Ingredient IBX-4041 IBX-4041 Testing vessel BV Blue active ingredient BVBlue active ingredient BVBlue substrates BV Blue substrates Chromogenic substrate IBX-4041 chromogenic substrate of sialidase enzyme Detection reagent for bacterial vaginosis (sialidase two-step method) Shenzhen BST Science & Technology Co., Ltd sells and exports chromogenic substrate of sialidase enzyme IBX-4041. Specification: Appearance: Light yellow solid powder Purity: 95% min Application: Two-step chromogenic substrates of neuraminidase (sialidase) BVBLUE Test Kit Component 1)BVBLUE Developer Solution: Water and Sodium hydroxide 2) BVBLUE Testing Vessel: Water, Potassium acetate, IBX-4041 (chromogenic substrate compound). IBX-4041 is the key ingredient of BVBLUE test kit, BVBLUE test is a rapid sialidase test for bacterial vaginosis. BVBLUE test method is currently the only test method approved by the FDA for testing Bacterial Vaginosis(BV), The BV BLUE Test contains a chromogenic substrate of sialidase enzyme, IBX-4041. BV Blue test is a commercially available test, it detects sialidase activity, an enzyme produced by BV-associated bacteria such as Gardnerella vaginalis, Bacteroides spp., Prevotella spp., and Mobiluncus spp. In the test procedure, a vaginal fluid sample is placed in the test vessel which contains a chromogenic substrate for sialidase. After incubation, a developer solution is added, and If the sample contained a high level of sialidase, a blue or green color is seen. Samples containing no sialidase, or low levels of this enzyme, will generate a yellow color in the reaction. The BV test has high specificity and sensitivity. The BVBlue test enables rapid detection of BV in a physician's office, and can thereby provide advantages over the Amsel methods and other methods requiring extensive laboratory testing. Advantage of BVBLUE Test Kit Compared to other diagnostic test methods for BV such as Amsel criteria, Nugent Gram-stain scoring system, Affirm�® Microbial Identification Test, BVBLUE Test Kit has following advantage: 1, BVBLUE Test is currently the only test method approved by the FDA for testing Bacterial Vaginosis(BV). 2, BVBLUE Test just take 10 minutes to 15 minutes to get the result. 3, High purity sialidase substrate with high specificity can reduce the occurrence of false positive. 4. Comparing with the gold standard, the coincidence rate is high, the relative sensitivity is 93%, and the specificity is 95%. 5. Easy to operate, do not need equipment. 6. The specimen does not need to pretreat.
nasal or throat swab, 25 tests per box, it has CE certificate
It has CE certificate, 1T per box, 540 tests per carton; 25T per box, 1000T per carton. high accuracy
25 tests per box, CE certificate
